RBBP4 pseudogene 7 (RBBP4P7)

RBBP4 pseudogene 7 (RBBP4P7) is classified as a pseudogene and does not encode a protein product. Pseudogenes are non-functional gene sequences that arise from duplication or retrotransposition events affecting functional genes, in this case *RBBP4*. Pseudogenes, including RBBP4P7, are generally not transcribed into functional proteins and typically have no known biological activities, disease roles, or interactions with drugs. The functional RBBP4 gene encodes a WD40 domain histone-binding protein involved in chromatin remodeling, epigenetic regulation, and cancer biology[1][2][3][5]. However, RBBP4P7 does not share these properties. There is no evidence that RBBP4P7 is used as a biomarker, is involved in human disease, or is a target for drug development. RBBP4P7 is a pseudogene and not a protein-coding gene; it is not a therapeutic target[1][2][3][5]. All major molecular functions and disease roles are associated with *RBBP4*, not its pseudogenes. Listing RBBP4P7 as a drug target or receptor is incorrect. If you are seeking drug target, biomarker, or disease information for “RBBP4” or “RBBP7,” refer to retinoblastoma-binding protein 4 (RBBP4) or retinoblastoma-binding protein 7 (RBBP7), both involved in chromatin remodeling, cancer biology, and other cellular functions[1][2][3][5].

Other names

RBBP4P7retinoblastoma-binding protein 4 pseudogene 7